Potential Clinical Benefits of D-ribose in Ischemic Cardiovascular Disease.

Cureus · 2018 · PMC5943027 · PMID 29750132

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

found that supplementation of D-ribose enabled Class II-III CHF patients with left ventricular dysfunction to maintain their maximal volume of oxygen (VO 2 max), improve their ventilatory efficiency, and experience a positive trend in their quality of life measurements (Carter O, MacCarter D, Mannebach S, et al.: D-ribose improves peak exercise capacity and ventilation efficiency in heart failure patients.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.